Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MNMD Mind Medicine > Detailed Quotes

MNMD Mind Medicine

3.310
-0.190-5.43%
Close 10/03 16:00 ET
3.290
-0.020-0.60%
Pre Mkt Price 10/04 05:47 ET
High
3.520
Open
3.500
Turnover
4.73M
Low
3.130
Pre Close
3.500
Volume
1.44M
Market Cap
94.24M
P/E(TTM)
Loss
52wk High
44.100
Shares
28.47M
P/E(Static)
Loss
52wk Low
2.850
Float Cap
83.33M
Bid/Ask %
-81.82%
Historical High
86.550
Shs Float
25.17M
Volume Ratio
0.30
Historical Low
2.850
Dividend TTM
--
Div Yield TTM
--
P/B
0.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
5.71%
Amplitude
11.14%
Avg Price
3.287
Lot Size
1
Float Cap
83.33M
Bid/Ask %
-81.82%
Historical High
86.550
Shs Float
25.17M
Volume Ratio
0.30
Historical Low
2.850
Dividend TTM
--
P/B
0.76
Dividend LFY
--
Turnover Ratio
5.71%
Amplitude
11.14%
Avg Price
3.287
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.
CEO: Mr. Robert B. Barrow
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...